Predictive Oncology's Skyline Medical Division Expands Its Asian Market Share with First-Ever Orders of STREAMWAY Systems in India
Aug 06, 2019 - GlobeNewswire
MINNEAPOLIS, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology, Inc. (Nasdaq: POAI) ("Predictive Oncology" or "the Company"), today announced its Skyline Medical division has received its first order from India for four machines to be sold to local hospitals.
"The sale of these four STREAMWAY units in India marks our entry into that country, and is an exciting milestone in our continued market expansion," commented Dr. Carl Schwartz, chief executive officer of Predictive Oncology.
The Indian healthcare industry is estimated to be more than $100 billion with the nation's medical device industry valued at more than $6 billi...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
